SB 6 amends California law to forbid maintaining or operating a business that keeps, displays, or offers drug paraphernalia unless those items are completely confined to a separate, signposted room or enclosure that excludes unaccompanied minors. Store owners and managers must prevent under‑18s from entering those spaces unless accompanied by a parent or guardian; minors are independently barred from entering unaccompanied.
The bill defines drug paraphernalia broadly, lists specific categories (including syringes, pipes, scales, packaging materials), and creates an explicit carve‑out: testing equipment used to detect contaminants or controlled substances — specifically naming fentanyl, ketamine, GHB, xylazine, and fentanyl analogs — is not “drug paraphernalia.” Enforcement is civil: violations do not create a criminal offense but may justify revoking, denying, or not renewing local licenses, permits, or entitlements to operate such businesses.
At a Glance
What It Does
Requires businesses that sell or display items defined as drug paraphernalia to confine them in a separate room or enclosure with clear signage and to bar unaccompanied minors from entering. It exempts medical prescribers, pharmacies, and licensed distributors for certain items and explicitly excludes testing equipment for fentanyl, xylazine, and similar substances from the paraphernalia definition.
Who It Affects
Retailers that sell smoking or drug‑use equipment (head shops, smoke shops, adult stores), venue owners with on‑site displays, local licensing authorities that issue business permits, and organizations that provide or distribute drug‑checking tools or testing supplies.
Why It Matters
The bill shifts enforcement from criminal sanctions to administrative licensing consequences and protects drug‑checking supplies used for harm reduction; that combination changes compliance priorities for retailers and empowers local licensing as the primary regulator of paraphernalia sales while preserving access to life‑saving testing tools.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
SB 6 creates a clear retail control regime for items the law defines as drug paraphernalia. If a business keeps, displays, or offers such items, it must place them wholly inside a separate room or enclosure; every entrance must have a visible sign warning that paraphernalia is kept there and that unaccompanied minors are excluded.
Store owners, managers, or anyone in charge of that enclosure must deny entry to anyone under 18 unless accompanied by a parent or legal guardian, and minors themselves are prohibited from entering those spaces unaccompanied.
The bill provides an expansive working definition of ‘drug paraphernalia’ and enumerates many commonly sold items — from hypodermic syringes and scales to a range of pipes, blenders, capsules, and packaging materials. It instructs courts and authorities which factors they may consider when determining whether a particular object qualifies as paraphernalia, including statements by the owner, advertising and display methods, prior convictions, and the existence of legitimate community uses.Crucially for public‑health actors, SB 6 excludes testing equipment from the paraphernalia definition when that equipment is designed or marketed to detect contaminants, toxic compounds, or controlled substances — and it names fentanyl, ketamine, GHB, xylazine, and fentanyl analogs as examples.
Separate statutory exemptions cover pharmacists and prescribers who dispense syringes by prescription and manufacturers, wholesalers, or retailers licensed by the State Board of Pharmacy to sell certain paraphernalia.Enforcement under SB 6 is administrative rather than criminal: breach of the section does not create a crime but serves as grounds for local licensing authorities to revoke, refuse to renew, or deny business licenses, permits, or other entitlements that authorize such sales. That creates a compliance regime driven by permitting and licensing decisions at the city or county level instead of traditional criminal prosecution.
The Five Things You Need to Know
The bill requires paraphernalia to be kept wholly within a separate room or enclosure and for each entrance to bear a visible sign excluding unaccompanied minors.
Minors under 18 cannot enter or remain in such enclosures unless accompanied by a parent or legal guardian; owners and managers must enforce that rule.
The statutory definition of ‘drug paraphernalia’ explicitly includes syringes, scales, packaging containers, various pipes, and testing equipment used to analyze controlled substances (subject to a carve‑out).
SB 6 exempts drug‑testing equipment from being ‘drug paraphernalia’ when it is intended to detect contaminants or controlled substances and specifically names fentanyl, ketamine, GHB, xylazine, and fentanyl analogs.
Violation of the section is not a criminal offense; instead, local authorities may revoke, refuse renewal, or deny business licenses, permits, or entitlements for businesses that sell paraphernalia.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Age‑restricted enclosures and operator duties
These subsections impose the core operational rule: paraphernalia must be completely confined within a separate room or enclosure to which persons under 18 who are not accompanied by a parent or guardian are excluded. Each entrance must be signposted with clear language about the contents and the age exclusion. The provision places direct obligations on the person in charge — owner, manager, or proprietor — to prevent minors from entering or remaining in those enclosures. Practically, retailers will need to redesign floor plans, add controlled access, and train staff on enforcement to comply.
Broad statutory definition and itemized examples
Subdivision (d) gives an expansive definition of ‘drug paraphernalia’ and then lists categories and specific items (kits, scales, diluents, blenders, packaging containers, syringes, and a wide array of pipes and smoking devices). The list creates low ambiguity for many common retail items but remains functional rather than exhaustive; anything intended or designed for introducing a controlled substance into the body can fall within the definition, which increases legal risk for sellers of items with both legitimate and illicit uses.
Factors for courts and authorities to determine intent
This subsection supplies ten nonexclusive factors that adjudicators may use to determine whether an object is paraphernalia, including owner statements, advertising, display manner, prior convictions, and legitimate community uses. The presence of these factors formalizes a multifactor intent test and gives local licensing bodies and courts room to consider context — which reduces mechanical determinations but raises potential for subjective or inconsistent application across jurisdictions.
Exemptions for medical/legal sellers and testing equipment carve‑out
Subdivision (f) exempts pharmacists and licensed medical prescribers when dispensing syringes by prescription, and retailers licensed by the State Board of Pharmacy for certain items. Subdivision (g) narrows the paraphernalia definition by excluding testing equipment that is designed or marketed to detect contaminants or controlled substances, and it explicitly lists fentanyl, ketamine, GHB, xylazine, and fentanyl analogs as examples. That carve‑out preserves the legal status of drug‑checking tools and reduces the risk that harm‑reduction supplies will be treated as paraphernalia.
Administrative enforcement through licensing, not criminal penalties
The statute removes criminal penalties for violating the section and instead makes violations grounds for revocation, nonrenewal, or denial of local business licenses, permits, or entitlements. This shifts enforcement into the administrative licensing arena, meaning local permitting bodies — not criminal prosecutors — will be the primary enforcers. The text does not create a new state licensing program or spell out procedural protections or timelines for administrative action, leaving those mechanics to existing local processes.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Minors and parents — by legally restricting minors’ access to retail displays of paraphernalia and forcing age‑segregated sales environments, the bill reduces the likelihood of incidental exposure or purchase by under‑18s.
- Harm‑reduction providers and public‑health programs — by excluding drug‑testing equipment (including xylazine detection) from the paraphernalia definition, the bill protects distribution and sale of life‑saving test kits and reduces legal risk for organizations performing drug‑checking.
- Local licensing authorities and municipal regulators — the bill arms permitting bodies with explicit statutory grounds to deny, revoke, or refuse renewal of licenses for businesses that fail to comply, providing a direct administrative enforcement lever.
- Licensed pharmacies and medical prescribers — the explicit exemptions for prescribers, pharmacists, and Board‑of‑Pharmacy‑licensed sellers clarify that certain syringe and medical device sales remain lawful and regulated.
Who Bears the Cost
- Retailers that sell smoking or paraphernalia items (head shops, smoke shops, convenience stores with related inventory) — they will incur costs to build separate enclosures, post signage, change store layouts, retrain staff, and face heightened licensing risk if they fail to comply.
- Small businesses and independent sellers — may face disproportionate financial and administrative burdens to meet enclosure and compliance requirements, and could lose local licenses without criminal proceedings.
- Local governments and licensing departments — must absorb administrative workload to adjudicate license revocations, denials, and nonrenewals, with potential need for new inspection protocols and staff time often without additional funding.
- Businesses selling dual‑use items (kitchen blenders, containers, glassware) — risk of subjective determinations under the multifactor test may force conservative inventory decisions or legal consultations to avoid enforcement actions.
Key Issues
The Core Tension
The bill seeks to protect minors and public health by restricting paraphernalia access while simultaneously preserving harm‑reduction tools; the central trade‑off is between preventing youth exposure through strong administrative controls and avoiding overbroad, subjective enforcement that could chill legitimate vendors and harm‑reduction services.
SB 6 pairs a broad, itemized definition of paraphernalia and a multifactor intent test with an administrative enforcement mechanism and a targeted carve‑out for testing equipment. That mix resolves some practical tensions — for example, protecting drug‑checking tools — but it creates others.
The mandatory enclosure and signage rule is administrable in theory, but the law leaves many operational details unspecified: how local inspectors will determine a ‘complete and wholly kept’ enclosure, whether temporary displays count, and what standard of proof licensing bodies must apply before revoking permits. Those gaps invite variable enforcement across cities and counties.
The multifactor list for determining paraphernalia introduces subjectivity: advertising, display, and prior convictions can tip a finding, which could ensnare legitimate vendors of dual‑use goods. Although the testing‑equipment carve‑out supports harm reduction, it hinges on whether equipment is ‘designed, marketed, intended to be used, or used’ for testing — language that may prompt litigation over a supplier’s marketing materials or the technical design of devices.
Finally, replacing criminal penalties with licensing consequences raises due‑process and proportionality questions: businesses could lose their livelihood through administrative action without the procedural safeguards of criminal trials, while public‑safety advocates may argue civil remedies lack sufficient deterrence.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.